PEDIATRIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)

Clinical trials for PEDIATRIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) explained in plain language.

Never miss a new study

Get alerted when new PEDIATRIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) trials appear

Sign up with your email to follow new studies for PEDIATRIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Finding the right dose: can a common treatment better control a rare childhood nerve disease?

Disease control Recruiting now

This study aims to find the best dose of a medication called Privigen (IVIG) to control symptoms and prevent relapses in children aged 2-17 with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), a rare disorder that damages nerves. Researchers will compare two different d…

Matched conditions: PEDIATRIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)

Phase: PHASE4 • Sponsor: CSL Behring • Aim: Disease control

Last updated Apr 03, 2026 14:42 UTC

PEDIATRIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)

Get alerted when new PEDIATRIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) trials appear

Finding the right dose: can a common treatment better control a rare childhood nerve disease?